Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

University Hospital, Rouen81 enrolled

Overview

the aims of SACHA study was to appreciate prevalence, evolution and follow-up, treatment response of patients with acquired hemophilia with biological and clinical data. Inclusion criteria were factor VIIIc below 30% associated with presence of Facgteur VIII inhibitor (titer \> 1 u Bethesda. Clinical and biologival data were obtained at Day 0 (as soon as possible and at 1, 3, 6 and 12 months.Informations were notified to co-investigators with the help of two french medical society (Internal medicine, french haemostasis and thrombosis society.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Acquired Haemophilia Register

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Factor VIIIc \< 30% and Factor VIII inhibitor \> 1 u Bethesda Exclusion Criteria: * absence and signed consent, haemophilia A

Locations (1)

University Hospital of Rouen

Rouen, France